Straumann Holding AG Other Current Assets 2012-2024 | SAUHY

Straumann Holding AG other current assets from 2012 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Straumann Holding AG other current assets for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Straumann Holding AG other current assets for 2024 were $0B, a 0% decline from 2023.
  • Straumann Holding AG other current assets for 2023 were $0B, a 0% decline from 2022.
  • Straumann Holding AG other current assets for 2022 were $0B, a 0% decline from 2021.
Straumann Holding AG Annual Other Current Assets
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $9
2011 $0
Straumann Holding AG Quarterly Other Current Assets
(Millions of US $)
2024-12-31
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31 $9
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.753B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.910B 21.47
Becton Dickinson (BDX) United States $49.385B 12.23
Cardinal Health (CAH) United States $36.396B 19.06
Labcorp (LH) United States $20.246B 16.42
Cooper (COO) United States $15.859B 21.03
West Pharmaceutical Services (WST) United States $14.979B 31.40
Align Technology (ALGN) United States $12.512B 24.84
Henry Schein (HSIC) United States $8.682B 14.89
Merit Medical Systems (MMSI) United States $5.621B 27.17
DENTSPLY SIRONA (XRAY) United States $3.159B 9.43
CONMED (CNMD) United States $1.734B 12.98
STAAR Surgical (STAA) United States $0.930B 0.00
Lifevantage (LFVN) United States $0.166B 17.14
Pro-Dex (PDEX) United States $0.149B 16.29